International Health
Volume 1, Issue 2 , Pages 141-147 , December 2009

Official development assistance for health–how neglected are neglected tropical diseases? An analysis of health financing

Received 15 July 2009 ,Revised 6 August 2009 ,Accepted 19 August 2009.

References 

  1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357:1018–1027
  2. WHO. A Turning Point: Report of the Global Partners’ Meeting on Neglected Tropical Diseases. Geneva: World Health Organization; 2007.
  3. WHO. Neglected Tropical Diseases, Hidden Successes, Emerging Opportunities. Geneva: World Health Organization; 2006. http://whqlibdoc.who.int/hq/2006/WHO_CDS_NTD_2006.2_eng.pdf [accessed 15 April 2009].
  4. OECD. Measuring Aid to Health. Paris: Organisation for Economic Co-Operation and Development; 2008. http://www.oecd.org/dataoecd/20/46/41453717.pdf [accessed 14 April 2009].
  5. Ravishankar N, Gubbins P, Cooley RJ, Leach-Kemon K, Michaud CM, Jamison DT, et al. Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet. 2009;373:2113–2124
  6. Shiffman J. Has donor prioritization of HIV/AIDS displaced aid for other health issues?. Health Policy Plan. 2008;23:95–100
  7. Kokotsis E. All G7/8 Commitments 1975-2006. Toronto: G8 Research Group; 2006. http://www.g8.utoronto.ca/evaluations/G8_commitments.pdf [accessed 15 April 2009].
  8. Moran M, Guzman J, Ropars A-L, McDonald A, Jameson N, Omune B, et al. Neglected disease research and development: how much are we really spending?. PLoS Med. 2009;6:e30
  9. WHO. Intensified Control of Neglected Diseases: Report of an International Workshop, Berlin, 10–12 December 2003. Geneva: World Health Organization; 2004.
  10. Canning D. Priority setting and the ‘neglected’ tropical diseases. Trans R Soc Trop Med Hyg. 2006;100:499–504
  11. Molyneux DH. Combating the “other diseases” of MDG 6: changing the paradigm to achieve equity and poverty reduction?. Trans R Soc Trop Med Hyg. 2008;102:509–519
  12. Hotez PJ, Molyneux DH, Fenwick A, Ottesen E, Ehrlich Sachs S, Sachs JD. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria: a comprehensive pro-poor health policy and strategy for the developing world. PLoS Med. 2006;3:e102
  13. OECD. User's Guide to the CRS Aid Activities database. Paris: Organisation for Economic Co-Operation and Development. http://www.oecd.org/dac/stats/crs/guide [accessed 14 April 2009].
  14. WHO. Global Plan to Combat Neglected Tropical Diseases 2008–2015. Geneva: World Health Organization; 2007. http://whqlibdoc.who.int/hq/2007/WHO_CDS_NTD_2007.3_eng.pdf [accessed 5 April 2009].
  15. The Global Network for Neglected Tropical Diseases. NTDs and the Global Network. Washington: The Global Network for Neglected Tropical Diseases; 2008. http://www.globalnetwork.org/files/ntds-global-network.pdf [accessed 8 July 2009].
  16. RTI International. About the Neglected Tropical Disease Control Program. Washington: RTI International; ©2007 [updated 3 August 2009]. http://ntd.rti.org/about/index.cfm?fuseaction=static&label=about [accessed 8 July 2009].
  17. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. Rescuing the bottom billion through control of neglected tropical diseases. Lancet. 2009;373:1570–1575
  18. Ottesen EA, Hooper PJ, Bradley M, Biswas G. The Global Programme to Eliminate Lymphatic Filariasis: health impact after 8 years. PLoS Negl Trop Dis. 2008;2:e317
  19. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Claeson M, et al. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet. 2006;367:1193–1208
  20. WHO. The control of neglected zoonotic diseases: a route to poverty alleviation. Report of a Joint WHO/DFID-AHP Meeting with the participation of FAO and OIE; Geneva, 20 and 21 September 2005. Geneva: World Health Organization; 2006. http://www.who.int/zoonoses/Report_Sept06.pdf [accessed 10 August 2009].
  21. Budke CM, Jiamin Q, Qian W, Torgerson PR. Economic effects of echinococcosis in a disease-endemic region of the Tibetan plateau. Am J Trop Med Hyg. 2005;73:2–10
  22. Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ. 2003;81:867–876
  23. Remme JHF, Feenstra P, Lever PR, Médici A, Morel C, Noma MH et al. Tropical diseases targeted for elimination: Chagas disease, lymphatic filariasis, onchocerciasis, and leprosy. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease Control Priorities in Developing Countries, 2nd ed. New York: Oxford University Press; 2006, p. 433-49. http://files.dcp2.org/pdf/DCP/DCP22.pdf [accessed 10 August 2009].
  24. Baltussen RMPM, Sylla M, Frick KD, Mariotti SP. Cost-effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol. 2005;12:91–101
  25. Molyneux DH. 10 years of success in addressing lymphatic filariasis. Lancet. 2009;373:529–530
  26. Heukelbach J, Winter B, Wilcke T, Muehlen M, Albrecht S, Sales de Oliveira FA, et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ. 2004;82:563–571
  27. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ. 2005;83:34–42
  28. Hotez PJ, Molyneux DH. Tropical anemia: one of Africa's great killers and a rationale for linking malaria and neglected tropical disease control to achieve a common goal. PLoS Negl Trop Dis. 2008;2:e270
  29. Molyneux DH, Hotez PJ, Fenwick A, Newman RD, Greenwood B, Sachs J. Neglected tropical diseases and the Global Fund. Lancet. 2009;373:296–297
  30. Stoever K, Molyneux D, Hotez P, Fenwick A. HIV/AIDS, schistosomiasis, and girls. Lancet. 2009;373:2025–2026
  31. Molyneux DH, Hotez PJ, Fenwick A. Rapid-Impact Interventions”: how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med. 2005;2:e336
  32. G8 Health Experts Group. Toyako Framework for Action on Global Health: Report of the G8 Health Experts Group. Hokkaido Toyako Summit, 7–9 July 2008. http://www.g7.utoronto.ca/summit/2008hokkaido/2008-healthexperts.pdf [accessed 15 April 2009].
  33. G8 Health Experts Group. Promoting Global Health: L’Aquila G8 Health Experts’ Report. L’Aquila Summit, 8–10 July 2009. http://www.g8italia2009.it/static/G8_Allegato/G8_Health_Experts_Report_and_Accountability,0.pdf [accessed 4 August 2009].
  34. Obama's Speech in Ghana. President addresses the Ghanaian Parliament in Accra. July 11, 2009. http://www.america.gov/st/texttrans-english/2009/July/20090711110050abretnuh0.1079783.html [accessed 4 August 2009].
  35. Novartis Foundation for Sustainable Development. Report 2001/2002. Basel: Novartis Foundation for Sustainable Development; 2002. http://www.novartisfoundation.org/platform/apps/Publication/getfmfile.asp?id=611&el=675&se=1054381294&doc=25&dse=1 [accessed 10 August 2009].
  36. Novartis AG. Annual Report 2007. Basel: Novartis International AG; 2008. http://www.novartis.com/downloads/investors/reports/NovAR07-web-E.pdf [accessed 10 August 2009].
  37. Sanofi-Aventis. Access to Medicines. Paris: Sanofi-Aventis; 2007. http://www.sanofi-aventis.tv/download/en/readDocument/access-to-medicines/39 [accessed 10 August 2009].
  38. Bayer AG. Sustainable Development Report 2007. Leverkusen: Bayer AG; 2008. http://www.sustainability2007.bayer.com/en/Sustainable-Development-Report-2007.pdfx [accessed 10 August 2009].
  39. Fenwick A. New initiatives against Africa's worms. Trans R Soc Trop Med Hyg. 2006;100:200–207
  40. Bayer AG. Sustainable Development Report 2005. Leverkusen: Bayer AG; 2006. http://www.sd2005.bayer.com/downloads/6608/6614/6861/Englisch_komplett.pdf [accessed 10 August 2009].
  41. PQMD. Guidelines. Partnership for Quality Medical Donations; ©1996–2009. http://www.pqmd.org/cms/PQMD_guidelines [accessed 18 April 2009].
  42. Guilloux A, Moon S. Hidden Price Tags: Disease-Specific Drug Donations: Costs and Alternatives. Access to Essential Medicines Campaign, Geneva: Médecins Sans Frontières; 2001. http://www.deolhonaspatentes.org.br/media/file/Publicacoes/hidden_price_tags.pdf [accessed 12 August 2009].
  43. Mectizan Donation Program. Mectizan Program Notes. Issue 33, 2004. http://www.mectizan.org/mpn33/mpnhtml336.htm [accessed 19 April 2009].
  44. Mectizan Donation Program. Annual Highlights of the Mectizan Donation Program 2004. Decatur, GA: Mectizan Donation Program; 2005.
  45. Mectizan Donation Program. Annual Highlights of the Mectizan Donation Program 2005. Decatur, GA: Mectizan Donation Program; 2006.
  46. Mectizan Donation Program. 2006 Annual Highlights. Decatur, GA: Mectizan Donation Program; 2007.
  47. Mectizan Donation Program. 2007 Annual Highlights. Decatur, GA: Mectizan Donation Program; 2008.
  48. GlaxoSmithKline plc. Answering the Questions that Matter: Corporate Responsibility Report 2007. Brentford, UK: GlaxoSmithKline plc; 2008.
  49. Pfizer, Inc. Strong Actions–Partnering for Positive Change. 2007 Corporate Responsibility Report. New York: Pfizer, Inc.; 2008. http://media.pfizer.com/files/corporate_citizenship/cr_report_2007.pdf [accessed 12 August 2009].
  50. ITI. Laying the Groundwork for the Elimination of Blinding Trachoma. 2003 Annual Report. New York: International Trachoma Initiative; 2004. http://www.trachoma.org/pdf/ar03.pdf [accessed 12 August 2009].
  51. ITI. Annual Report 2004. New York: International Trachoma Initiative; 2005. http://www.trachoma.org/pdf/ar04.pdf [accessed 12 August 2009].
  52. ITI. Annual Report 2005. New York: International Trachoma Initiative; 2006. http://www.trachoma.org/pdf/ar05.pdf [accessed 12 August 2009].
  53. ITI. Saving Sight, Transforming Lives: Trachoma Control and Human Development. Annual Report 2006. New York: International Trachoma Initiative; 2007. http://www.trachoma.org/pdf/06annual.pdf [accessed 12 August 2009].
  54. ITI. 2007: Success in Sight. Annual Report 2007. New York: International Trachoma Initiative; 2008. http://www.trachoma.org/pdf/AR2007.pdf [accessed 12 August 2009].
  55. Johnson & Johnson. 2007 Worldwide Contributions Program Annual Report. New Brunswick: Johnson & Johnson; 2008.
  56. McCoy D, Kembhavi G, Patel J, Luintel A. The Bill & Melinda Gates Foundation's grant-making programme for global health. Lancet. 2009;373:1645–1653
  57. Bill & Melinda Gates Foundation grants database. http://www.gatesfoundation.org/grants/Pages/search.aspx [accessed 27 April 2009].

PII: S1876-3413(09)00035-7

doi: 10.1016/j.inhe.2009.08.004

International Health
Volume 1, Issue 2 , Pages 141-147 , December 2009

Article Tools

* Image Usage & Resolution